Notice of Results
Source: RNSCambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Notice of Results
Cambridge Cognition Holdings plc ("the Company"), which develops and markets neuroscience technology to assess brain health, will announce its interim results to 30 June on 19 September 2019.
Enquiries
|
Cambridge Cognition Holdings PLC Steven Powell, Chief Executive Officer Matthew Stork, Chief Operating Officer |
Tel: 01223 810 700 |
|
finnCap Ltd (NOMAD and Joint Broker) Geoff Nash / Simon Hicks Alice Lane / Manasa Patil |
Tel: 020 7220 0500 (Corporate Finance) (ECM) |
|
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant |
Tel: 020 3903 7715
|
|
IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Miles Nolan / Zach Cohen |
Tel: 020 3934 6630
|
About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.
For further information visit www.cambridgecognition.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
